TRAIL Receptor-1 (CT) Blocking Peptide

TRAIL Receptor-1 (CT) Blocking Peptide

Product No.: D277

[product_table name="All Top" skus="D277"]

- -
- -
DeathTNF-Related Apoptosis Inducing Ligand Receptor-1
Product Type
Blocking Peptide
Alternate Names
TNFRSF10A, APO2, CD261, DR4, MGC9365

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Product Concentration
0.2 mg/ml
Amino Acid Location
This peptide sequence is located at amino acids 427 to 445 of Human DR4 protein.
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Tumor necrosis factor-related apoptosis-inducing ligand Receptor 1 (TRAIL-R1) is a cell-surface receptor involved in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell-death signaling.1 The death ligand TRAIL bears high potential as a new anticancer agent, as binding to the death receptors TRAIL-R1 or TRAIL-R2 triggers apoptosis in most cancer cells.2

Antigen Details

References & Citations

1. Yoo, NJ. et al. (2001) Oncogene 20: 399
2. Eberle, J. et al. (2005) J Investigative Dermatol. 125: 1010
3. Rimm, D. et al. (2005) Clin Cancer Research 11
- -
- -
Products are for research use only. Not for use in diagnostic or therapeutic procedures.